Accordingly, and in contrast to Imatinib, acadesine neither activated caspase 3 (Figure 1D) nor it induced phosphatidyethanolamine externalisation in K562 and other CML cells (Figure S1 E and F). The gene discussed is CASP3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.